Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. - Wikidata - wikimedia - TriplyDB

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

http://www.wikidata.org/entity/Q33699077

about

Insights on common vaccinations in HIV-infection: efficacy and safety Hepatitis B vaccine antibody response and the risk of clinical AIDS or death The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults.Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection.Self-reported history of sexually transmissible infections (STIs) and STI-related utilization of the German health care system by men who have sex with men: data from a large convenience sample.Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1 Cofactors that may influence vaccine responses.The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings.Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.

P2860

Q26770665-5F86FD22-E2A3-444C-8186-40E4F4A229A1 Q28730976-FF5DD61E-590F-40E2-8879-2F40FA4C49B8 Q33525046-50DA1EE4-CA65-4BC6-943A-C13604B39471 Q33587716-CC04B487-7D5D-477A-8E6D-9C9542C5A127 Q33630150-0FB068B1-631C-4FE7-9DAA-78165121F383 Q33745613-98D4C4D2-5931-46B6-A904-1BD55445AFED Q33904688-6321B80B-A4D6-4484-8A66-223CDEA8A8DB Q34077801-0F3544EE-E0F7-4545-833C-14754652441E Q34297930-BC2B0237-4078-4682-BA41-840F3A0CC201 Q34514263-1DB795A8-7C4F-4BAD-ACEB-32CAF6142203 Q34813175-4FDC3B4E-7E30-42D6-8F23-CDB2F87AB5D4 Q35000898-57D2AB5D-A67D-4F0B-A7CF-CDED0991247D Q35441596-97D964CD-0D39-4D91-947F-E9AD6565D771 Q36178032-457FBC1C-952A-4B3B-A20B-A7F7A172A5E1 Q36240585-209F755F-BE19-4B01-AA01-A14646264635 Q36698116-477DCADF-5373-4C30-A4AC-413D8D65D2D7 Q37028187-AA01DB06-D807-4E35-8B31-4ADE87D84C34 Q37254537-F456109E-C2D9-42E7-BD12-2023719916A4 Q37989146-56D398D8-B3C1-418B-B1C1-FE0BB03EB9DC Q40560650-5DB3FA5A-26CF-4A29-9FAB-9FEDB7166CC1 Q41546085-3D5986CD-C241-47EE-B553-6911F5FF8B05 Q43667277-47087CCF-873C-4FB5-85F7-213878BAF419 Q45365130-33B7A82F-11F3-46FA-8B51-B15C88D00338

P2860

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

http://www.wikidata.org/entity/Q33699077

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@ast

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@en

type

label

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@ast

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@en

prefLabel

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@ast

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@en

P1433

Q33699077-ECD10D63-1895-4D2E-8DE4-9CA82B9F07B9

P1476

Q33699077-AD0CDA8A-3979-4DB6-A590-0CB6CE6FE0DF

P2093

Q33699077-1A5B0A02-8912-4FE3-9ACE-594025C0680B

Q33699077-487E20C6-77CF-47AD-AE4B-42AEB014EDCB

Q33699077-77099B7B-FA87-4293-A5B6-7A9419B28190

Q33699077-8C9439A1-9FC2-4789-824F-3B7BDF9B8B03

Q33699077-AA1C5771-04F3-428A-800A-034AB9F42FD8

Q33699077-B9DD5EE2-B54A-462C-9D47-95061F76F1DC

Q33699077-C24C3379-7CDC-492A-90DB-A3AA00C2BE71

Q33699077-D90E502F-F497-45A6-A6CC-3889016BAA65

Q33699077-EBD1D9D1-3241-440A-9C67-B4F07668D1F5

Q33699077-F659CF1D-8826-4D5E-9849-10D41E131177

P2860

Q33699077-173550B7-8323-47E0-BFE7-B111DA5AEACE

Q33699077-1D4A8209-4304-4432-94AE-CBB61E1C09BD

Q33699077-2CA0F738-3E8E-439C-9EC2-ED3C3968CC6E

Q33699077-319BE24D-8F6A-49E6-95AD-CC2A64846D41

Q33699077-37F3ED49-1F04-4421-8161-D6F6EA7534B0

Q33699077-459F9B7C-145A-4882-9235-0E8FEBEF43BB

Q33699077-46262000-EAA0-48E6-BACE-C38628340D31

Q33699077-4923C01D-E855-4C4A-BC25-89E5F0FB75CF

Q33699077-4C535F68-67A0-4EC0-8A65-928A2895F967

Q33699077-597D5360-4579-4E1A-89B0-A91F7DF2DCE3

P304

Q33699077-AF3F2156-2111-4D6D-B923-106D2BBA6B4C

P31

Q33699077-9F2D2973-0544-4727-BBF4-0E53EF837318

P356

Q33699077-8EBA131F-DBEC-444A-922B-79139EE1990D

P407

Q33699077-AC9C1D13-5D4C-4A83-8A79-73CF9717A5CD

P433

Q33699077-221833CA-4071-40CE-9267-195E7C294B86

P478

Q33699077-38A6E795-B959-47AC-AB7D-4A320A643516

P50

Q33699077-82ECE08D-3561-4E5E-BDB3-8BEE6265B3DD

Q33699077-E8EA4813-66C8-4551-97E7-16AC7DD28F5E

Q33699077-EE410FD4-86BA-4856-AA5D-9C1D8DC04090

P577

Q33699077-1257A6C6-70D4-4EDD-BD0D-2C002A99AE43

P698

Q33699077-D92C3193-8367-4273-A94E-CFCFCF998402

P932

Q33699077-A2EDF682-0A14-4E64-AE54-DC8771EE6358

P356

QAD.0B013E32832CD99E

P1433

P1476

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.

@en

P2093

Amy C Weintrob

http://www.w3.org/2001/XMLSchema#string

Ann Fieberg

http://www.w3.org/2001/XMLSchema#string

Helen M Chun

http://www.w3.org/2001/XMLSchema#string

Infectious Disease Clinical Research Program HIV Working Group

http://www.w3.org/2001/XMLSchema#string

Katherine Huppler Hullsiek

http://www.w3.org/2001/XMLSchema#string

Matthew J Dolan

http://www.w3.org/2001/XMLSchema#string

Michael L Landrum

http://www.w3.org/2001/XMLSchema#string

Nancy F Crum-Cianflone

http://www.w3.org/2001/XMLSchema#string

R Vincent Barthel

http://www.w3.org/2001/XMLSchema#string

Robert J O'Connell

http://www.w3.org/2001/XMLSchema#string

P2860

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

Immunology of hepatitis B virus and hepatitis C virus infection

Propensity score modeling strategies for the causal analysis of observational data.

Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule.

Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.

P304

545-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32832CD99E

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Vincent C Marconi

Anuradha Ganesan

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19487908

http://www.w3.org/2001/XMLSchema#string

P932

2831117

http://www.w3.org/2001/XMLSchema#string